Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days' therapy. 1981

R H Schwartz, and R L Wientzen, and F Pedreira, and E J Feroli, and G W Mella, and V L Guandolo

The effect of duration of orally administered penicillin V potassium on the bacteriologic and clinical cure of group A streptococcal pharyngitis was evaluated. One hundred ninety-one middle-class patients received either seven days (96 patients) or ten days (95 patients) of therapy. Compliance with taking penicillin was assessed by multiple methods, including penicillinuria. Throat cultures were obtained during therapy and three times in the three weeks after therapy. M-precipitin and T-agglutinin typing were done on paired isolates of group A streptococci from patients who had recurrences. Patients treated for seven days had a significantly greater failure rate (30/96 [31%]) compared with patients receiving ten days of penicillin (17/95 [18%]). Compliance rates were high; 66% to 81% of patients showed penicillinuria throughout the study period. Treatment failure was not a function of poor compliance in either treatment group. The data support the current recommendation for ten full days of penicillin therapy and suggest that persistence of streptococci in the throat after adequate therapy may be common.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D010404 Penicillin V A broad-spectrum penicillin antibiotic used orally in the treatment of mild to moderate infections by susceptible gram-positive organisms. Penicillin, Phenoxymethyl,Apocillin,Beromycin,Beromycin, Penicillin,Berromycin, Penicillin,Betapen,Fenoxymethylpenicillin,Pen VK,Penicillin V Potassium,Penicillin V Sodium,Penicillin VK,Phenoxymethylpenicillin,V-Cillin K,Vegacillin,Penicillin Beromycin,Penicillin Berromycin,Phenoxymethyl Penicillin,Potassium, Penicillin V,Sodium, Penicillin V,V Cillin K,V Sodium, Penicillin,VCillin K
D010612 Pharyngitis Inflammation of the throat (PHARYNX). Sore Throat,Pharyngitides,Sore Throats,Throat, Sore
D010614 Pharynx A funnel-shaped fibromuscular tube that conducts food to the ESOPHAGUS, and air to the LARYNX and LUNGS. It is located posterior to the NASAL CAVITY; ORAL CAVITY; and LARYNX, and extends from the SKULL BASE to the inferior border of the CRICOID CARTILAGE anteriorly and to the inferior border of the C6 vertebra posteriorly. It is divided into the NASOPHARYNX; OROPHARYNX; and HYPOPHARYNX (laryngopharynx). Throat,Pharynxs,Throats
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic

Related Publications

R H Schwartz, and R L Wientzen, and F Pedreira, and E J Feroli, and G W Mella, and V L Guandolo
February 1987, American journal of diseases of children (1960),
R H Schwartz, and R L Wientzen, and F Pedreira, and E J Feroli, and G W Mella, and V L Guandolo
January 1994, Scandinavian journal of infectious diseases,
R H Schwartz, and R L Wientzen, and F Pedreira, and E J Feroli, and G W Mella, and V L Guandolo
August 1996, The Pediatric infectious disease journal,
R H Schwartz, and R L Wientzen, and F Pedreira, and E J Feroli, and G W Mella, and V L Guandolo
March 1985, The Journal of pediatrics,
R H Schwartz, and R L Wientzen, and F Pedreira, and E J Feroli, and G W Mella, and V L Guandolo
January 1988, Scandinavian journal of infectious diseases,
R H Schwartz, and R L Wientzen, and F Pedreira, and E J Feroli, and G W Mella, and V L Guandolo
October 1994, Archives of pediatrics & adolescent medicine,
R H Schwartz, and R L Wientzen, and F Pedreira, and E J Feroli, and G W Mella, and V L Guandolo
April 2002, The Pediatric infectious disease journal,
R H Schwartz, and R L Wientzen, and F Pedreira, and E J Feroli, and G W Mella, and V L Guandolo
October 1991, The Pediatric infectious disease journal,
R H Schwartz, and R L Wientzen, and F Pedreira, and E J Feroli, and G W Mella, and V L Guandolo
September 2004, The Pediatric infectious disease journal,
R H Schwartz, and R L Wientzen, and F Pedreira, and E J Feroli, and G W Mella, and V L Guandolo
January 2005, Scandinavian journal of infectious diseases,
Copied contents to your clipboard!